The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Determining optimal sequencing of anti-PD-1 and BRAF-targeted therapy: A phase II randomised study of neoadjuvant pembrolizumab with/without dabrafenib and trametinib (D+T) in BRAF V600 mutant resectable stage IIIb/c/d melanoma (NeoTrio trial).
 
Maria Gonzalez
No Relationships to Disclose
 
Alexander M. Menzies
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Robyn Saw
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Amgen
Travel, Accommodations, Expenses - Amgen
 
Andrew J. Spillane
No Relationships to Disclose
 
Omgo E. Nieweg
No Relationships to Disclose
 
Kerwin F. Shannon
No Relationships to Disclose
 
John F. Thompson
No Relationships to Disclose
 
Julie R. Howle
No Relationships to Disclose
 
Sydney Ch'ng
No Relationships to Disclose
 
Jonathan Stretch
No Relationships to Disclose
 
Monica Osorio
No Relationships to Disclose
 
Louise Emmett
Consulting or Advisory Role - Oncosil
Speakers' Bureau - Janssen
 
Helen Rizos
No Relationships to Disclose
 
Alexander David Guminski
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Merck; Pfizer; Regeneron; Sun Pharma
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Medivation/Astellas
 
Matteo S. Carlino
Honoraria - Bristol-Myers Squibb; MSD; Novartis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Richard A. Scolyer
No Relationships to Disclose
 
Georgina V. Long
Honoraria - Bristol-Myers Squibb; Incyte; Merck; Novartis; Roche
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Incyte; MERCK; Novartis; Pierre Fabre; Roche/Genentech